Categories: Health

Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer

 | Source: Life Backup Plan by Galacxia, Inc

Aliso Viejo, CA, July 11, 2025 (GLOBE NEWSWIRE) — Galacxia, Inc., the developer of the Life Backup Plan app, is issuing a clarification to our July 10, 2025 press release. Annette Slyman will not be joining the team in any capacity, due to extenuating circumstances.

Plans evolve. Our mission stays the course.

We continue to hold Ms. Slyman in the highest regard. Galacxia remains committed to delivering innovative digital health and safety solutions that improve lives and support communities nationwide.

About Life Backup Plan by Galacxia, Inc.

Life Backup Plan is an end-to-end safety, emergency detection, digital health and multi-faceted care app that reduces tragedies, improves outcomes, lowers medical costs, and eases the burden on families and the healthcare system. Unlike other health and personal safety systems that require pressing a button to summon help, Life Backup Plan proactively checks on people, shares critical health data, coordinates support, and handles everything from emergency response to long-term caregiving, end-of-life planning, and daily logistics. We’re delivering a comprehensive solution that bridges fragmented systems, supports value-based care, and brings modern tools into a system still largely reliant on fax machines.. 

Galacxia, Inc. is a SBA certified Woman-Owned Small Business and Delaware C Corporation committed to transforming personal safety, emergency response, and health access and equity.

Eyes on the stars. Hands on the wheel. Heart in the mission.

Press inquiries

Life Backup Plan by Galacxia, Inc
https://www.lifebackupplan.com
Sandy Eulitt
founder@lifebackupplan.com
8588480860
49 El Prado Lane, Oceanside, CA 92058

GlobeNews Wire

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

36 minutes ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

36 minutes ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

36 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

37 minutes ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

37 minutes ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

37 minutes ago